JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
First Citizens BancShares
FCNCA
$23.4B
| $8.34M | ﹤0.01% |
20,690
-948
| -4% | -$380K |
2013 Q2
18 quarters
|
|
2177
State Street SPDR S&P Dividend ETF
SDY
$20.5B
| $8.32M | ﹤0.01% |
88,071
+5,968
| +7% | +$559K |
2013 Q2
18 quarters
|
|
2178
Gibraltar Industries
ROCK
$1.18B
| $8.32M | ﹤0.01% |
252,087
+1,374
| +0.5% | +$43.9K |
2013 Q2
18 quarters
|
|
2179
Crocs
CROX
$5.72B
| $8.31M | ﹤0.01% |
657,670
+542,030
| +469% | +$5.81M |
2013 Q2
18 quarters
|
|
|
AHRT
2180
AH Realty Trust
AHRT
$457M
| $8.31M | ﹤0.01% |
535,146
+49,172
| +10% | +$730K |
2014 Q2
14 quarters
|
|
2181
CALL
Trip.com Group
TCOM
$24.4B
| $8.28M | ﹤0.01% |
187,800
+137,800
| +276% | +$6.59M |
2017 Q2
2 quarters
|
|
|
PDCE
2182
DELISTED
PDC Energy, Inc.
PDCE
| $8.28M | ﹤0.01% |
160,584
+79,186
| +97% | +$3.75M |
2013 Q2
18 quarters
|
|
2183
Blackstone Mortgage Trust
BXMT
$1.9B
| $8.27M | ﹤0.01% |
256,994
+84,799
| +49% | +$2.72M |
2013 Q2
18 quarters
|
|
|
AET
2184
PUT
DELISTED
Aetna Inc
AET
| $8.26M | ﹤0.01% |
45,800
+25,300
| +123% | +$4.35M |
2017 Q1
3 quarters
|
|
|
ROCC
2185
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $8.26M | ﹤0.01% |
211,176
+22,097
| +12% | +$843K |
2016 Q4
4 quarters
|
|
2186
PUT
AB InBev
BUD
$144B
| $8.23M | ﹤0.01% |
73,800
+43,900
| +147% | +$5.16M |
2017 Q3
1 quarter
|
|
|
TGNA
2187
DELISTED
TEGNA Inc
TGNA
| $8.23M | ﹤0.01% |
584,592
+522,319
| +839% | +$6.83M |
2013 Q2
18 quarters
|
|
2188
AMN Healthcare
AMN
$1.39B
| $8.2M | ﹤0.01% |
166,421
-59,793
| -26% | -$2.73M |
2013 Q2
18 quarters
|
|
|
AMWD
2189
DELISTED
American Woodmark
AMWD
| $8.2M | ﹤0.01% |
62,937
+30,921
| +97% | +$3.25M |
2013 Q3
17 quarters
|
|
|
PDCO
2190
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $8.19M | ﹤0.01% |
+226,700
| New | +$8.28M |
2017 Q4
0 quarters
|
|
2191
Axsome Therapeutics
AXSM
$9.54B
| $8.15M | ﹤0.01% |
1,455,864
-3,253
| -0.2% | -$16.4K |
2015 Q4
8 quarters
|
|
2192
Ziff Davis
ZD
$1.94B
| $8.15M | ﹤0.01% |
124,843
-30,010
| -19% | -$1.96M |
2013 Q2
18 quarters
|
|
2193
Belden
BDC
$4.23B
| $8.14M | ﹤0.01% |
105,540
+76,980
| +270% | +$6.36M |
2013 Q2
18 quarters
|
|
2194
Gray Television
GTN
$464M
| $8.12M | ﹤0.01% |
484,923
+32,989
| +7% | +$515K |
2015 Q2
10 quarters
|
|
2195
PUT
Lowe's Companies
LOW
$102B
| $8.11M | ﹤0.01% |
87,300
-252,700
| -74% | -$20.9M |
2017 Q1
3 quarters
|
|
2196
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.3B
| $8.11M | ﹤0.01% |
61,060
+3,924
| +7% | +$511K |
2015 Q2
10 quarters
|
|
2197
Clearway Energy Class C
CWEN
$5.98B
| $8.11M | ﹤0.01% |
428,787
+196,053
| +84% | +$3.72M |
2013 Q3
17 quarters
|
|
2198
Deutsche Bank
DB
$66B
| $8.1M | ﹤0.01% |
425,671
-5,577,058
| -93% | -$101M |
2013 Q2
18 quarters
|
|
2199
Haemonetics
HAE
$4.75B
| $8.1M | ﹤0.01% |
139,466
+53,904
| +63% | +$2.84M |
2015 Q4
8 quarters
|
|
2200
PennyMac Financial
PFSI
$3.22B
| $8.1M | ﹤0.01% |
362,353
-7,647
| -2% | -$151K |
2014 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.